PharmaShots | Incisive News in 3 Shots

Subscribe Now

Revance Therapeutics

Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) Receives the US FDA’s Approval as First Therapeutic Indication for Cervical Dystonia

Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) Receives the US FDA’s Approval as First Therapeutic Indication for Cervic...

August 14, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us